ORIC Pharmaceuticals hosts Q4/FY2021 call; corporate presentation furnished as Exhibit 99.1

Oric Pharmaceuticals, Inc.

Company held conference call on March 21, 2022 to discuss Q4 and full year 2021 financial results and operational update.
Corporate presentation attached as Exhibit 99.1 but specific financial figures are not included in the filing text.
Filing under Item 7.01 Regulation FD; presentation is furnished, not filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.